# A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis

> **NCT01813643** · PHASE4 · TERMINATED · sponsor: **Wei Hao** · enrollment: 50 (actual)

## Conditions studied

- Methamphetamine Dependence

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT01813643
- **Lead sponsor:** Wei Hao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2013-12
- **Final completion:** 2014-08
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Effects of aripiprazole was not obvious and showed adverse reaction obviously
- **Last updated:** 2015-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01813643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01813643, "A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01813643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*